糖尿病患者肾小球高滤过的发生机制及治疗新进展

被引：6

作者：

薛昊 ^{[1
]}

姚卿 ^{[1
]}

梅长林 ^{[1
]}

机构：

[1] 第二军医大学附属长征医院肾内科

来源：

临床肾脏病杂志 | 2018年 / 18卷 / 03期

基金：

国家重点研发计划;

关键词：

糖尿病患者; 肾小球;

D O I：

暂无

中图分类号：

R587.2 [糖尿病性昏迷及其他并发症]; R692.9 [其他疾病];

学科分类号：

1002 ; 100201 ; 100210 ;

摘要：

糖尿病已经成为最常见的导致慢性肾脏病(CKD)的病因,进一步引起终末期肾病(ESRD)、心血管疾病以及死亡。在过去5年里,尽管加强了干预力度,但因糖尿病所致的糖尿病肾脏疾病(DKD)患者的数量还在不断增加。因此,进一步改善防控策略是很有必要的。在糖尿病人群中,除蛋白尿外,肾小球滤过率(GFR)的下降也是ESRD和

引用

页码：184 / 187

页数：4

共 12 条

[1] 中国成人糖尿病肾脏病临床诊断的专家共识
中华医学会内分泌学分会
[J]. 中华内分泌代谢杂志, 2015, 31 (05) : 379 - 385
[2] Renal Effects of DPP-4 Inhibitor Sitagliptin or GLP-1 Receptor Agonist Liraglutide in Overweight Patients With Type 2 Diabetes: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial[J] . Lennart Tonneijck,Mark M Smits,Marcel HA Muskiet,Trynke Hoekstra,Mark HH Kramer,AH Jan Danser,Piet M ter Wee,Michaela Diamant,Jaap A Joles,Dani?l H vanRaalte.Diabetes Care . 2016 (11)
[3] Elevated baseline glomerular filtration rate (GFR) is independently associated with a more rapid decline in renal function of patients with type 1 diabetes[J] . Hilary J. Thomson,Elif I. Ekinci,Nicholas J. Radcliffe,Jas-mine Seah,Richard J. MacIsaac,George Jerums,Erosha Premaratne.Journal of Diabetes and Its Complications . 2015
[4] Glucagon-like peptide 1 receptor agonist (GLP-1 RA): long-term effect on kidney function in patients with type 2 diabetes[J] . Bernt Johan von Scholten,Tine Willum Hansen,Jens Peter Goetze,Frederik Persson,Peter Rossing.Journal of Diabetes and Its Complications . 2015 (5)
[5] Protein- and diabetes-induced glomerular hyperfiltration: role of glucagon, vasopressin, and urea[J] . Lise Bankir,Ronan Roussel,Nadine Bouby.AJP: Renal Physiology . 2015 (1)
[6] Pleiotropic effects of type 2 diabetes management strategies on renal risk factors
Muskiet, Marcel H. A.
Tonneijck, Lennart
Smits, Mark M.
Kramer, Mark H. H.
Heerspink, Hiddo J. Lambers
van Raalte, Danil H.
[J]. LANCET DIABETES & ENDOCRINOLOGY, 2015, 3 (05): : 367 - 381
[7] Diabetic Kidney Disease: A Report From an ADA Consensus Conference[J] . Tuttle,Katherine R,Bakris,George L,Bilous,Rudolf W,Chiang,Jane L,de Boer,Ian H,Goldstein-Fuchs,Jordi,Hirsch,Irl B,Kalantar-Zadeh,Kamyar,Narva,Andrew S,Navaneethan,Sankar D,Neumiller,Joshua J,Patel,Uptal D,Ratner,Robert E,Whaley-Connell,Adam T,Molitch,Mark E.Diabetes Care . 2014 (10)
[8] Glomerular Hyperfiltration and Renal Disease Progression in Type 2 Diabetes
Ruggenenti, Piero
Porrini, Esteban L.
Gaspari, Flavio
Motterlini, Nicola
Cannata, Antonio
Carrara, Fabiola
Cella, Claudia
Ferrari, Silvia
Stucchi, Nadia
Parvanova, Aneliya
Iliev, Ilian
Dodesini, Alessandro Roberto
Trevisan, Roberto
Bossi, Antonio
Zaletel, Jelka
Remuzzi, Giuseppe
[J]. DIABETES CARE, 2012, 35 (10) : 2061 - 2068
[9] Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis[J] . Caroline S Fox,Kunihiro Matsushita,Mark Woodward,Henk JG Bilo,John Chalmers,Hiddo J Lambers Heerspink,Brian J Lee,Robert M Perkins,Peter Rossing,Toshimi Sairenchi,Marcello Tonelli,Joseph A Vassalotti,Kazumasa Yamagishi,Josef Coresh,Paul E de Jong,Chi-Pang Wen,Robert G Nelson.The Lancet . 2012 (9854)
[10] Effect of a High-Protein Diet on Kidney Function in Healthy Adults: Results From the OmniHeart Trial[J] . Stephen P. Juraschek,Lawrence J. Appel,Cheryl A.M. Anderson,Edgar R. Miller.American Journal of Kidney Diseases . 2012

← 1 2 →